A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects with Active Noninfectious Uveitis (Gilead)
All Posts
LUMINA
A Phase III, Multicenter, Sham-Controlled, Randomized, Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye (LUMINA)
Yao Liu, MD, MS, Discusses Eye Care During COVID-19 With Wisconsin Public Radio
Dr. Yao Liu, assistant professor and glaucoma specialist, spoke with Kate Archer Kent of the Wisconsin Public Radio Morning Show on Monday, September 28. Dr. Liu discussed eye care during the COVID-19 pandemic, including what …
AURA 201
A Phase 2 Trial of AU-011 Via Suprachoroidal Administration with a Dose Escalation Phase (Open-label, Ascending Single and Repeat Dose) and a Randomized, Masked Dose Expansion Phase Designed to Evaluate the Safety and Efficacy of AU-011 in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
TALON
A 64-Week, Two-Arm, Randomized, Double-Masked, Multi-Center, Phase IIIb Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Aflibercept 2 mg in a Treat-To-Control Regimen in Patients with Neovascular Age-Related Macular Degeneration (TALON)
PHOTON
A Randomized, Double-Masked, Active-Controlled Phase 2/3 Study of the Efficacy and Safety of High-Dose Aflibercept in Patients with Diabetic Macular Edema (PHOTON)
PULSAR
Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients with Neovascular Age-Related Macular Degeneration (PULSAR)
Combat Blindness International Virtual World Sight Day
Our partners at Combat Blindness International’s (CBI) are hosting a virtual World Sight Day celebration on Oct. 8, 2020 from 7-8:30 p.m., and all UW-DOVS faculty and staff are invited! Sign up today! This online …
Roomasa Channa, MD, Joins DOVS Retina Faculty
The Department of Ophthalmology and Visual Sciences welcomed Roomasa Channa, MD, vitreoretinal surgeon, to the DOVS faculty on September 21, 2020. Dr. Channa comes to us from the Baylor College of Medicine and Michael E. …